Bioresorbable Scaffolds Market Professional Overview 2018-2027 Major Vendors like Abbott Vascular, Biotronik, REVA Medical, Inc., Xenogenics Co. and More

Bioresorbable Scaffolds Market - Key Players

Some of the key players in this market are:

Abbott Vascular (U.S.)
Biotronik (GER)
Kyoto Medical Planning Co. Ltd. (JP)
REVA Medical, Inc. (U.S.)
Xenogenics Corp. (U.S.)

Get sample report @ https://www.marketresearchfuture.com/sample_request/1251

Bioresorbable Scaffolds Market - Highlights

Bioresorbable Scaffolds are like stents which are used during cardiovascular surgeries. They are valuable tools used for the treatment of different coronary diseases. According to WHO in 2014, approximately 18 million people died from cardiovascular diseases. Increasing prevalence of cardiovascular diseases, rising diabetic & obese population, and rapid development in technology have boosted this market’s growth.

In addition to this, increasing stress, poor diet and lack of exercise have also contributed in the growth of this market. However, availability of alternative therapy may restrain this market’s growth. The Global Bioresorbable Scaffolds Market is expected to grow at a CAGR of 18.9% during forecasted period 2017-2023.

Bioresorbable Scaffolds Market - Competitive Analysis

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

In April-2016, Abbott entered into a definitive agreement with St. Jude Medical Inc. which led to its acquisition. This created a premier medical device leader with top positions in high-growth cardiovascular markets, including atrial fibrillation, structural heart and heart failure as well as a leading position in the high-growth neuromodulation market. Under the agreement, St. Jude Medical shareholders received USD 46.75 in cash and 0.8708 shares of Abbott common stock, representing total consideration of approximately USD 85 per share. At an Abbott stock price of USd 43.93, this represented a total transaction equity value of USD 25 billion.

In June-2016, BIOTRONIK commercially launched of Solia S ProMRI, with a 5.6 French lead body, the smallest MR conditional pacing lead making it available in the U.S in 45, 53 and 60-centimeter lengths.

Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/1251

In July-2017, REVA Medical, Inc completed the reduction in its workforce in connection with the commercialization of its Fantom scaffold. A total of 11 full-time employees were let go, with 49 full-time employees remaining, in the transition from research and development activities to commercial activities. The Company estimates that it will incur aggregate cash charges of approximately USD 420,000 associated with the workforce reduction, comprising approximately USD 410,000 in severance payments and approximately USD 10,000 in continuation of benefits.

Bioresorbable Scaffolds Market - Intended Audience

Medical devices manufacturing companies
Research and development (R&D) companies
Government and independent research laboratories
Government and independent regulatory authorities
Academic medical institutes and universities
Pharmaceutical industries

Bioresorbable Scaffolds Market - Segments

Global Bioresorbable Scaffolds Market has been segmented on the basis of types which comprises of Absorbable magnesium stent (AMS), Polymeric scaffold, poly carbonate scaffold, Poly salicylic acid stent, Myolimus-eluting Poly-L-Lactic acid scaffold, Everolimus-eluting Poly-L-lactic acid scaffold and others. On the basis of applications, the market is segmented into peripheral vascular intervention, regulation of blood flow and others. On the basis of end users, market is segmented into Hospitals, clinics, research institutes and others.

Bioresorbable Scaffolds Market - Regional Analysis

The Global Bioresorbable Scaffolds Market is dominated by America owing to the presence of huge population suffering from cardiovascular diseases, presence of number of leading companies and increasing geriatric population. Moreover, increasing obese and diabetic population, lack of exercise, increasing stress and desk-bound lifestyle has provided push for the growth of the market. Followed by the Americas, Europe has the second largest market due to the availability of huge research funds and increasing government support. Moreover, increasing healthcare expenditure along with the presence of developed economies like the Italy, Germany, France, and others within the region fuels the market growth within the region. Asia Pacific accounts for the fastest growing market due to the rapid development in technology, growing healthcare industry and a huge patient suffering. On the other hand, the Middle East & Africa accounts the least share in global Bioresorbable Scaffolds Market, especially due to the presence of poor economies within the African region.

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/1251

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued….

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.